Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Aphidius gifuensis

ABSTRACT: Aphidius gifuensis Genome sequencing and assembly

PROVIDER: PRJNA615161 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	JACMRX01.dat.gz	Other
	JACMRX01.fasta.gz	Fasta.gz
	JACMRX01.master.dat	Other
	SRR11577200_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 108

Similar Datasets

Aphidius gifuensis

Project description:Aphidius gifuensis overview

| PRJNA681665 | ENA

Aphidius gifuensis

Project description:Aphidius gifuensis population genomics

| PRJNA852353 | ENA

Aphidius gifuensis

Project description:Aphidius gifuensis transcriptome Raw sequence reads

| PRJNA495936 | ENA

Aphidius ervi

Project description:Aphidius ervi Transcriptome sequencing

| PRJNA377544 | ENA

Aphidius ervi

Project description:Aphidius ervi overview

| PRJNA397802 | ENA

Aphidius ervi strain:SA

Project description:Aphidius ervi strain:SA Genome sequencing and assembly

| PRJNA347567 | ENA

Aphidius ervi

Project description:Aphidius ervi venom apparatus transcriptome

| PRJNA235942 | ENA

Aphidius ervi strain:APA strain

Project description:Aphidius ervi APA strain genome, Raw sequence reads

| PRJNA549674 | ENA

Project description:Aphidius ervi genome

| PRJNA540742 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data